- JP-listed companies
- KISSEI PHARMACEUTICAL CO.,LTD.
- Income statement
KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】Income statement
Market cap
¥229B
P/E ratio
15.6x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 64,618 | 62,491 | 70,399 | 70,110 | 71,294 | 71,706 | 74,009 | 72,297 | 63,234 | 69,044 | 65,381 | 67,493 | 75,579 | 88,330 |
| Cost of revenue | - | - | - | 24,063 | 23,582 | 25,076 | 25,878 | 26,735 | 28,340 | 36,321 | 34,143 | 35,118 | 38,238 | 44,265 |
| Gross profit | - | - | - | 46,047 | 47,711 | 46,630 | 48,131 | 45,562 | 34,893 | 32,723 | 31,238 | 32,374 | 37,341 | 44,065 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 8,334 | 10,274 | 8,491 | 9,887 | 6,202 | 1,857 | 1,505 | -1,402 | -1,129 | 4,017 | 5,773 |
| Operating expenses | - | - | - | 37,710 | 37,439 | 38,140 | 38,232 | 39,363 | 33,048 | 31,217 | 32,640 | 33,503 | 33,324 | 38,291 |
| Income before tax | 8,326 | 8,849 | 13,541 | 10,584 | 11,353 | 9,638 | 11,414 | 7,169 | 2,429 | 3,476 | 562 | 598 | 6,142 | 6,974 |
| Provision for income taxes | - | - | - | 3,277 | 2,940 | 2,351 | 2,598 | 1,586 | 1,741 | 2,098 | 3,475 | 3,046 | 3,159 | 3,634 |
| Net income | 4,593 | 4,702 | 8,729 | 7,188 | 8,195 | 7,765 | 9,098 | 5,535 | 2,888 | 5,378 | 13,032 | 10,634 | 11,289 | 11,975 |
| Earnings per share | 91.35 | 97.52 | 176.67 | 142.14 | 166.89 | 158.74 | 188.26 | 117.33 | 60.31 | 113.25 | 280.2 | 228.31 | 246.61 | 274.21 |
| Dividend per share | 36 | 38 | 40 | 42 | 44 | 46 | 48 | 50 | 52 | 54 | 56 | 80 | 82 | 100 |